摘要
糖尿病足感染(diabetic foot infection,DFI)是糖尿病(diabetes mellitus,DM)常见的并发症之一,可导致截肢甚至死亡。近年来,多重耐药(multi-drug resistant,MDR)菌的流行更是给DFI的临床诊治带来严峻挑战。基于DFI的流行病学和患者个体化的病原学分析,及时、合理应用有效的抗菌药物是改善患者预后的关键措施。本文围绕DFI相关方面的研究进展进行综述,旨在为临床工作提供参考。
Diabetic foot infection(DFI) is one of the common complications of diabetes mellitus, which can lead to amputation or even death. Recently, the prevalence of multi-drug resistant bacteria has posed a serious challenge to the diagnosis and treatment of DFI in the clinical context. Based on the epidemiology of DFI and individualized pathogenic analysis, timely and rational administration of effective antibiotics is a vital measure to improve patients’ prognosis. This review focuses on research updates in such aspects of DFI, with the purpose of providing a reference for clinical work.
作者
张一卓
陈轶坚
ZHANG Yi-zhuo;CHEN Yi-jian(Institute of Antibiotics,Huashan Hospital,Fudan University,Shanghai 200040,China)
出处
《中国临床医学》
2023年第1期18-23,共6页
Chinese Journal of Clinical Medicine
基金
2021年国家临床重点专科建设项目—华山医院糖尿病足多学科联合诊疗团队建设。
关键词
糖尿病
糖尿病足溃疡
糖尿病足感染
糖尿病足骨髓炎
抗菌药物
diabetes mellitus
diabetic foot ulcers
diabetic foot infection
diabetic foot osteomyelitis
antibiotics
